Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinomaJi Ma(Lanzhou Army General Hospital), Wenchao Liu(Air Force Medical University)BMC CancerMarch 11, 201410.1186/1471-2407-14-172Cited by 61SaveCiteExport RISWatch citationsRelated PapersOverexpression of PAD4 suppresses drug resistance of NSCLC cell lines to gefitinib through inhibiting Elk1-mediated epithelial-mesenchymal transition|Oncology Reports|2016|29